Santen Pharmaceutical Co., Ltd. (4536)

Name: Santen Pharmaceutical Co., Ltd. (4536) — storico dei bilanci
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Storico di ricavi, utili e flussi di cassa dai bilanci ufficiali.

Healthcare · Wall Street (USA) · Ultimo aggiornamento: 2026-10-02

Santen Pharmaceutical Co., Ltd. engages in the research and development, production, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally. The company operates through Medical drugs, Over-the-counter drugs, Medical equipment, and others segments.

Dati chiave

Capitalizzazione di mercato: JPY 529 billion
Ricavi (esercizio chiuso a 2026-03-31): JPY 291.6B
Utile netto: JPY 37.4B
Margine lordo: 58.2%
Margine netto: 12.8%

Vedi grafici interattivi e bilanci completi → Modello di valutazione (DCF) →

Conto economico annuale

Conto economico	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Entrate totali	JPY 291.6B	JPY 300.0B	JPY 302.0B	JPY 279.0B
Utile lordo	JPY 169.7B	JPY 171.0B	JPY 178.7B	JPY 166.1B
Risultato Operativo (EBIT)	JPY 47.8B	JPY 46.9B	JPY 38.5B	(JPY 3.1B)
Reddito netto	JPY 37.4B	JPY 36.3B	JPY 26.6B	(JPY 14.9B)

Fonte: bilanci pubblici della società (SEC). Verificare su SEC EDGAR prima di fare affidamento su qualsiasi cifra.

Stati patrimoniali, flussi di cassa, dati trimestrali e indici completi nel visualizzatore interattivo di 4536. /companies/us/4536

Aziende simili

Le informazioni di questo sito sono solo a scopo educativo e informativo; non costituiscono consulenza finanziaria. Non vengono pubblicati prezzi obiettivo né raccomandazioni.

English version →Tutte le azioni

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.